95253 ⎘
Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing three or more hetero rings
Pyridazinone compounds and uses thereof
#902HETEROARYLAMINOPYRIMIDINE AMIDE AUTOPHAGY INHIBITORS AND METHODS OF USE THEREOF
#903PFKFB3 INHIBITORS AND THEIR USES
#904Nrf2 REGULATORS
#905NOVEL HETEROARYL-SUBSTITUTED AMINOALKYL AZOLE COMPOUNDS AS PESTICIDES
#906Biarylmethyl heterocycles
#9073,3-difluoroallylamines or salts thereof and pharmaceutical compositions comprising the same
#908Certain chemical entities, compositions, and methods
#909MATRIPTASE 2 INHIBITORS AND USES THEREOF
#910ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES
#9111,5-disubstituted 1,2,3-triazoles are inhibitors of Rac/CDC42 GTPases
#912Substituted indole Mcl-1 inhibitors
#913PROCESS FOR THE PREPARATION OF PIPERIDINE COMPOUNDS
#914Quaternary indazole glucocorticoid receptor antagonists
#915CYCLOALKANE-1,3-DIAMINE DERIVATIVE
#916COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE
#917RHO-ASSOCIATED PROTEIN KINASE INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND PREPARATION METHOD AND USE THEREOF
#918Quinolin-2-one derivatives
#919SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS
#920Protease inhibitors as antivirals
#921BIARYL ETHER-TYPE QUINAZOLINE DERIVATIVES
#922Light-Emitting Device and Light-Emitting Apparatus
#9235-HETEROARYL-1H-PYRAZOL-3-AMINE DERIVATIVE
#924N-(HETEROARYL) QUINAZOLIN-2-AMINE DERIVATIVES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF
#925HETEROBIFUNCTIONAL COMPOUNDS AS DEGRADERS OF HPK1
#926PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT FACTOR D MEDICAL DISORDERS
#927Modulators of Rho-associated protein kinase
#928Amide-substituted heterocyclic compounds for the treatment of conditions related to the modulation of IL-12, IL-23 and/or IFN-alpha
#929EGFR INHIBITORS
#930SUBSTITUTED ISOINDOLONYL 2,2'-BIPYRIMIDINYL COMPOUNDS, ANALOGUES THEREOF, AND METHODS USING SAME
#931Benzolactam compounds as protein kinase inhibitors
#932PHTHALAZINONE DERIVATIVES
#933MATRIX METALLOPROTEINASE (MMP) INHIBITORS AND METHODS OF USE THEREOF
#934INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
#935COMPOUNDS FOR THE TREATMENT OF HIV
#936Selective octahydro-cyclopenta[c]pyrrole negative modulators of NR2B
#937A CONJUGATION LINKER CONTAINING 2,3-DIAMINOSUCCINYL GROUP
#938ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES
#939BENZAMIDES OF PYRAZOLYLAMINO- PYRIMIDINYL DERIVATIVES, AND COMPOSITIONS AND METHODS THEREOF
#940PESTICIDALLY ACTIVE FUSED BICYCLIC HETEROAROMATIC COMPOUNDS
#941PYRIMIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR PREVENTING OR TREATING CANCERS INCLUDING THE SAME
#942COMPOUNDS AND USES THEREOF
#943Fused ring compounds
#944COMPOUNDS AND MODULES FOR INHIBITION OF PRE-miR-21 AND THEIR USE IN TREATMENT OF CERTAIN CANCERS
#945INHIBITORS FOR THE B-CATENIN/B-CELL LYMPHOMA 9 (BCL9) PROTEIN-PROTEIN INTERACTION
#946Small Molecule Compound
#947CHEMICAL COMPOUND AS THYROID HORMONE BETA RECEPTOR AGONIST AND USE THEREOF
#948AMINOPYRAZINE DERIVATIVES AS PI3K-y INHIBITORS
#949INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
#950HTT modulators for treating Huntington's disease
#951COMPOSITIONS IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION COMPRISING AMYLIN, AN AMYLIN RECEPTOR AGONIST OR AN AMYLIN ANALOG AND A CO-POLYAMINO ACID
#952ORGANIC ELECTROLUMINESCENT DEVICE
#953METHODS AND COMPOSITIONS FOR MODULATING SPLICING
#954Trialkyne linking agents and methods of use
#9555-heteroaryl substituted indazole-3-carboxamides and preparation and use thereof
#956INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF
#957Organic photodetector and electronic device including the same
#958ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES
#959BENZIMIDAZOYL GLP-1 RECEPTOR AGONISTS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, AND METHODS FOR THEIR USE
#960LIVER TARGETING DRUG, PHARMACEUTICAL COMPOSITION AND USE THEREOF
#961NOVEL HETEROCYCLIC COMPOUNDS
#962Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disorders
#963Cycloalkyl pyrimidines as ferroportin inhibitors
#964TREATMENT OF GVHD
#965JAK INHIBITOR COMPOUND AND USE THEREOF
#966COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE
#967INHIBITORS OF CYCLIN-DEPENDENT KINASES
#968(AZA)INDAZOLYL-ARYL SULFONAMIDE AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS
#969ORGANIC MOLECULES FOR USE IN LIGHT-EMITTING DEVICES
#9701,4-DISUBSTITUTED PYRIDAZINE ANALOGS THERE OF AND METHODS FOR TREATING SMN-DEFICIENCY-RELATED CONDITIONS
#971ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC APPLIANCE
#972Anti-cancer nuclear hormone receptor-targeting compounds
#973Organic molecules for optoelectronic devices
#974Pyrazine-2(1H)-ketone compound preparation method
#975PHARMACEUTICAL COMPOUNDS
#976ORGANIC LIGHT-EMITTING DEVICE
#977LUMINESCENCE DEVICE AND NITROGEN-CONTAINING COMPOUND FOR SAME
#978Heterocyclic compounds and uses thereof
#979ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE
#980INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
#981METHODS AND COMPOSITIONS FOR TREATING CANCER
#982LIGHT-EMITTING DEVICE AND METHOD OF MANUFACTURING THE SAME
#983OXO SIX-MEMBERED CYCLOPYRIMIDINE COMPOUND, PREPARATION METHOD AND MEDICAL USE THEREOF
#984Novel Ferroportin Inhibitors
#985Pyrazolyl derivatives useful as anti-cancer agents
#986T-TYPE CALCIUM CHANNEL BLOCKER
#9874-carboxamido-isoindolinone derivatives as selective PARP-1 inhibitors
#988Organic light-emitting device comprising emission layer satisfying specific singlet excitation energy level conditions
#989INHIBITORS OF HEPATITIS C VIRUS REPLICATION
#9903,5-DISUBSTITUTED PYRAZOLE COMPOUNDS AS KINASE INHIBITORS AND USES THEREOF
#991AMIDE-SUBSTITUTED HETEROCYCLIC COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFN ALPHA RESPONSES
#992Polymorphic forms of kinase inhibitor compound, pharmaceutical composition containing same, preparation method therefor and use thereof
#993Substituted 3-phenoxyazetidin-1-yl-pyrazines
#994ISOINDOLINE DERIVATIVES
#995TETRAZINES FOR HIGH CLICK RELEASE SPEED AND YIELD
#996Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
#997Compositions for treating neurodegenerative diseases
#9987-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same
#999BENZIMIDAZOLE INHIBITORS OF PAD ENZYMES
#1000N-(1H-IMIDAZOL-2-YL)BENZAMIDE COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME AS ACTIVE INGREDIENT
#1001INHIBITORS OF ENCEPHALITIC ALPHAVIRUSES
#1002ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE
#1003ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE
#1004PYRIDAZINONE DERIVATIVE
#1005HETEROCYLIC COMPOUND AND LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE HETEROCYCLIC COMPOUND
#1006Compounds and pharmaceutical compositions thereof for the treatment of diseases
#1007INDOLE DERIVATIVE-CONTAINING INHIBITOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#1008COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES
#1009SUBSTITUTED HETEROCYCLIC DERIVATIVES AS PI3K INHIBITORS
#1010Inhibitors of APOL1 and methods of using same
#1011ORGANIC ELECTROLUMINESCENCE DEVICES
#1012Compound, nanoribbon, and semiconductor device
#1013ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES
#1014Imidazole-containing inhibitors of ALK2 kinase
#1015SULFONAMIDE COMPOUNDS AS CARDIAC SARCOMERE ACTIVATORS
#1016ANTIBACTERIAL COMPOUNDS
#1017Inhibitors of LRRK2 kinase
#1018INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF
#1019THERAPEUTIC COMPOUNDS
#1020INHIBITORS OF CBL-B AND METHODS OF USE THEREOF
#1021CALPAIN MODULATORS AND THERAPEUTIC USES THEREOF
#1022SARS-3CL PROTEASE INHIBITORS
#1023(Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases
#1024LIGHT-EMITTING DEVICE INCLUDING ORGANOMETALLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE ORGANOMETALLIC COMPOUND
#1025ALK-5 inhibitors and uses thereof
#1026Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders
#1027INHIBITORS OF RET
#1028Materials for organic electroluminescent devices
#1029MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES
#1030Substituted 4-aminoisoindoline-1,3-dione compounds, compositions thereof, and methods of treatment therewith
#1031COMPOUNDS USEFUL FOR TREATING GASTROINTESTINAL TRACT DISORDERS
#1032Tricyclic compounds as BCR-ABL inhibitors
#1033FACTOR XIIA INHIBITORS
#1034COMPOUNDS AND COMPOSITIONS AS MODULATORS OF TLR SIGNALING
#1035PYRAZOL-3-ONES THAT ACTIVATE PRO-APOPTOTIC BAX
#1036HETEROCYCLIC DERIVATIVE AND USE THEREOF
#1037BENZAMIDES OF PYRAZOLYLAMINO- PYRIMIDINYL DERIVATIVES, AND COMPOSITIONS AND METHODS THEREOF
#1038HETEROCYCLIC COMPOUNDS AS ADENOSINE ANTAGONISTS
#1039ENZYME INHIBITORS
#1040ALKYNYL QUINAZOLINE COMPOUNDS
#1041LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME
#1042HIGH THROUGHPUT METHOD FOR CONSTRUCTING AND SCREENING COMPOUND LIBRARY AND REACTION DEVICE
#1043ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES
#1044Dihydrobenzimidazolones for medical treatment
#1045Analogs for the treatment of disease
#1046Crystal forms C and E of pyrazin-2(1H)-one compound and preparation method therefor
#1047ARYL SULFONAMIDES AS SMALL MOLECULE STAT3 INHIBITORS
#1048HETEROCYCLIC COMPOUNDS AS MNK INHIBITORS
#1049MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES
#1050COMPOUND, MIXTURE THEREOF, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC DEVICE
#1051INHIBITORS OF TYROSINE KINASE
#1052MONOCYCLIC AGONISTS OF STIMULATOR OF INTERFERON GENES STING
#1053COMPOUNDS AND METHODS OF TREATING RNA-MEDIATED DISEASES
#1054COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE
#1055Crystal form D of pyrazine-2(1H)-ketone compound and preparation method therefor
#1056Bisamide sarcomere activating compounds and uses thereof
#1057Lysophosphatidic acid receptor 1 (LPAR1) inhibitor compounds
#1058HETEROCYCLIC COMPOUNDS AS KINASE INHIBITOR AND USES THEREOF
#1059ETHYNYLHETEROCYCLES AS RHO-ASSOCIATED COILED-COIL KINASE (ROCK) INHIBITORS
#1060LIGHT-EMITTING DEVICE INCLUDING FUSED CYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE FUSED CYCLIC COMPOUND
#1061ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME
#10625-BROMO-INDIRUBINS
#1063Fused ring pyrimidine amino compound and preparation method, pharmaceutical composition, and use thereof
#1064QUENCHER AND USES THEREOF
#1065Deuterium-containing compound, and organic light-emitting device comprising same
#1066HETEROCYCLIC AMIDE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF
#1067Anti-cancer compounds
#1068Modulators of estrogen receptor proteolysis and associated methods of use
#1069ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT
#1070NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES
#10711-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
#1072METHOD FOR PRODUCING RADIOACTIVE METAL COMPLEX
#1073HETEROCYCLIC INHIBITORS OF MCT4
#10741-CYANO-PYRROLIDINE COMPOUNDS AS USP30 INHIBITORS
#1075HETEROCYCLIC COMPOUND, A LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND AN ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE
#1076MODIFIED CYANINE DYES AND CONJUGATES THEREOF
#1077Compounds and compositions for treating conditions associated with STING activity
#1078WDR5 INHIBITORS AND MODULATORS
#1079AMINE-SUBSTITUTED HETEROCYCLIC COMPOUNDS AS EHMT2 INHIBITORS AND METHODS OF USE THEREOF
#1080SUBSTITUTED BENZENECARBOXAMIDES AS IL-17A MODULATORS
#1081BISHETEROCYCLIC CARBONYL SUBSTITUTED DIHYDROPYRAZOLE COMPOUND, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF
#1082ALLOSTERIC EGFR INHIBITORS AND METHODS OF USE THEREOF
#1083AMINO QUINAZOLINE DERIVATIVES AS P2X3 INHIBITORS
#1084KRAS G12C INHIBITORS AND USES THEREOF
#1085Pyridine and pyridimine compounds as PI3K-gamma inhibitors
#1086IDENTIFICATION AND USE OF KRAS INHIBITORS
#1087PCSK9 INHIBITORS AND METHODS OF USE THEREOF
#1088Light-emitting device, light-emitting apparatus, electronic device, and lighting device
#1089JAK1 SELECTIVE KINASE INHIBITOR
#1090Cyclen based compounds, coordination compounds, peptides, pharmaceutical preparation, and use thereof
#1091HETEROCYCLIC COMPOUNDS AND USES THEREOF
#1092Nitrogen-containing compound, organic electroluminescent device and electronic apparatus
#1093ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES
#1094Organic Light Emitting Device
#1095Antagonists of the muscarinic acetylcholine receptor M
#1096Selective small molecule peptidomimetic melanocortin ligands
#1097Aminopyrazine diol compounds as PI3K-γ inhibitors
#1098INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
#1099NOVEL HETEROCYCLIC-SUBSTITUTED PYRIMIDINE DERIVATIVE EXHIBITING CANCER CELL GROWTH INHIBITORY EFFECT, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
#1100PYRIMIDINE COMPOUND AND PREPARATION METHOD THEREFOR
#1101RECEPTOR TYROSINE KINASE INHIBITORS FOR TREATMENT OF PROTEIN KINASE MODULATION-RESPONSIVE DISEASE OR DISORDER
#11024,4-DISUBSTITUTED CYCLOHEXYL BRIDGED HEPTAMETHINE CYANINE DYES AND USES THEREOF
#1103Curable composition, cured product, and compound
#1104Next Generation Synthetic Transcription Factors
#1105CRYSTAL FORMS OF A PYRIDAZINONE TRPC INHIBITOR
#1106TRISUBSTITUTED BENZENE COMPOUND HAVING NITROGEN-CONTAINING HETERO RING IN MOLECULAR TERMINUS AND ORGANIC ELECTROLUMINESCENCE ELEMENT
#11071-cyano-pyrrolidine derivatives as dub inhibitors
#1108Piperazine amide derivative, preparation method therefor, and use thereof in medicine
#1109N-substituted indole derivatives as PGE2 receptor modulators
#1110Heterocyclic derivative and organic electroluminescent device thereof
#1111METHOD FOR SELECTING MATERIAL FOR ORGANIC LIGHT-EMITTING DEVICE
#1112PYRROLIDINE COMPOUNDS
#1113PESTICIDALLY ACTIVE AZOLE-AMIDE COMPOUNDS
#1114Chiral bisamino-ether compounds, and method of preparation and use thereof
#1115MYST family histone acetyltransferase inhibitors
#1116SOLID FORMS OF A PARP7 INHIBITOR
#1117Solid forms of an HPK1 inhibitor
#1118Inhibitors of cysteine proteases and methods of use thereof
#1119SMALL MOLECULE MODULATORS OF IL-17
#1120ISOPRENOIDS AND METHODS OF MAKING THEREOF
#1121BIFUNCTIONAL COMPOUNDS
#1122HERBICIDALLY ACTIVE 4-(4-TRIFLUORMETHYL-6-CYCLOROPYLPYRAZOLYL)PYRIMIDINES
#1123Inhibitors Of Plasma Kallikrein
#1124Inhibitors of lysine specific demethylase-1
#1125SUBSTITUTED INDAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS
#1126QUINOLINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF CANCER
#1127Isoindolinone substituted indoles and derivatives as RAS inhibitors
#1128Azolopyrimidine for the treatment of cancer-related disorders
#1129PHOSPHOROUS HOST MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME
#1130ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE-1 (ENPP1) INHIBITORS AND USES THEREOF
#1131COMPOUNDS AND METHODS FOR TARGETING HSP90
#1132HETEROCYCLE-SUBSTITUTED BICYCLIC AZOLE PESTICIDES
#1133Compounds, compositions, and methods
#1134PYRAZOLYL QUINOXALINE KINASE INHIBITORS
#1135METAL/RADIOMETAL-LABELED PSMA INHIBITORS FOR PSMA-TARGETED IMAGING AND RADIOTHERAPY
#1136CARBAZOLE DERIVATES FOR USE IN OPTOELECTRONIC DEVICES
#1137SUBSTITUTED PYRROLIDINE AMIDES II
#1138HERBICIDAL COMPOUNDS
#1139INDAZOLYL-ISOXAZOLE DERIVATIVES FOR THE TREATMENT OF DISEASES SUCH AS CANCER
#1140QUINAZOLINE AND INDOLE COMPOUNDS TO TREAT MEDICAL DISORDERS
#1141IMMUNOMODULATOR
#1142Compounds and methods for inhibiting JAK
#1143COMPOUND, COMPOSITIONS, AND METHODS
#1144BRD4-JAK2 INHIBITORS
#1145HETEROCYCLIC COMPOUNDS AS ADENOSINE ANTAGONISTS
#1146ARYLQUINAZOLINES
#1147Heterocyclic g-protein-coupled receptor 52 (GPR52) agonists
#1148HEXONE GLUCOKINASE INHIBITOR AND USE THEREOF
#1149BIS(DIAZIRINE) DERIVATIVES AS PHOTO-CROSSSLINKER FOR TREATING CORNEAL ECTATIC DISORDERS
#1150SUBSTITUTED PYRROLIDINE AMIDES V
#1151ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION HAVING ANTICANCER ACTIVITY
#11522-OXOQUINAZOLINE DERIVATIVES AS METHIONINE ADENOSYLTRANSFERASE 2A INHIBITORS
#1153DIRECT AMPK ACTIVATORS
#1154TREATMENT OF ACANTHAMOEBA OR BALAMUTHIA TROPHOZOITES AND/OR CYSTS
#1155SUBSTITUTED PYRROLIDINE AMIDES III
#1156NLRP3 modulators
#1157Method for treating cancer using a combination of DNA-damaging agents and DNA-PK inhibitors
#1158Heteroaryl inhibitors of PAD4
#1159Pyrimidinone derivatives as CDC7 inhibitors
#1160ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME
#1161METHODS OF TREATING OR PREVENTING AUTOIMMUNE DISEASES WITH 2,4-PYRIMIDINEDIAMINE COMPOUNDS
#1162Tri-substituted imidazoles for the inhibition of TGF beta and methods of treatment
#1163Functionalized peptides as antiviral agents
#1164Compound for organic optoelectronic device, organic optoelectronic device, and display device
#1165Sting agonist compounds and methods of use
#1166KINASE INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE
#1167BENZIMIDAZOLE COMPOUNDS AS C-KIT INHIBITORS
#1168EBNA1 inhibitors and methods using same
#1169Compound for organic electronic device, organic electronic device using same, and electronic apparatus thereof
#1170NUCLEAR TRANSPORT MODULATORS AND USES THEREOF
#1171FARNESOID X RECEPTOR AGONISTS AND USES THEREOF
#1172Bicycloheptane pyrrolidine orexin receptor agonists
#1173PHENYLPYRROLIDINE COMPOUND AND USE THEREOF
#1174DUAL FUNCTION MOLECULES FOR HISTONE DEACETYLASE INHIBITION AND ATAXIA TELANGIECTASIA MUTATED ACTIVATION AND METHODS OF USE THEREOF
#1175HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, METHOD FOR MANUFACTURING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER
#1176PYRAZOLE COMPOUNDS SUBSTITUTED WITH HETEROARYL AND PHARMACEUTICAL USE THEREOF
#1177Enzyme inhibitors
#1178METHODS AND COMPOSITIONS FOR MODULATING SPLICING
#1179PROCESSES FOR THE PREPARATION OF ARGINASE INHIBITORS AND THEIR SYNTHETIC INTERMEDIATES
#1180HETEROAROMATIC COMPOUNDS AS VANIN INHIBITORS
#1181Solid forms of 3-((1R,3R)-1-(2,6-difluoro-4-((1-(3-fluoropropyl)azetidin-3- yl)amino)phenyl)-3-methyl-1,3,4,9-tetrahydro-2H-pyrido[3,4-b]indol-2-yl)-2,2-difluoropropan-1-ol and processes for preparing fused tricyclic compounds comprising a substituted phenyl or pyridinyl moiety, including methods of their use
#1182SUBSTITUTED QUINOXALINE COMPOUNDS AS INHIBITORS OF FGFR TYROSINE KINASES
#1183Compounds and Compositions for Eye Treatments
#1184Compound and organic light emitting device comprising the same
#1185Diamine compound, and polyimide precursor and polyimide film using same
#1186SYNTHESIS OF NANOTUBULAR MOLECULES
#1187INDOLIN-2-ONE OR PYRROLO -PYRIDIN -2 -ONE DERIVATIVES
#1188Diaryl-azole compound and formulation for controlling harmful organism
#1189FUNCTIONALIZED PEPTIDES AS ANTIVIRAL AGENTS
#1190Prodigiosin analogs and methods of use
#1191Poly-ADP ribose polymerase (PARP) inhibitors
#1192COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME
#1193COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
#1194COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
#1195COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF
#1196sGC STIMULATORS
#1197Disubstituted pyrazole compounds
#1198CONJUGATES OF BIVALENT EVANS BLUE DYE DERIVATIVES AND METHODS OF USE
#1199Pyrazole compounds and uses thereof
#1200TYROSINE KINASE 2 INHIBITORS, PREPARATION METHODS AND MEDICINAL USES THEREOF